Markets:

Overview

News

Currencies

International

Treasuries

Design Therapeutics, Inc. - Common Stock (NQ:DSGN)

13.99 +0.22 (+1.60%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Design Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Shares of Design Therapeutics Are Plummeting on Tuesday ↗

August 15, 2023

The biotech company released phase 1 trial details regarding a Friedreich ataxia therapy.

Via The Motley Fool

Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 15, 2023

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 15, 2023

Via Benzinga

Crude Oil Down 2%; Home Depot Posts Upbeat Earnings ↗

August 15, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 90 points on Tuesday. The Dow traded down 0.75% to 35,042.16 while the NASDAQ fell 0.66% to 13,697.15. The S&P...

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 ↗

August 15, 2023

Via Benzinga

Dow Falls Over 200 Points; US Retail Sales Top Expectations ↗

August 15, 2023

U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.67% to 35,069.60 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 15, 2023

Via Benzinga

Why Is Design Therapeutics Stock Moving Lower Today? ↗

August 15, 2023

Design Therapeutics Inc (NASDAQ: DSGN) reported initial results from the company's Phase 1 multiple-ascending dose (MAD) clinical trial of DT-216 in

Via Benzinga

Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket ↗

August 15, 2023

Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 15, 2023

Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday!

Via InvestorPlace

Design Therapeutics, Getty Images, Sea Limited And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 15, 2023

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 14, 2023

Via Benzinga

Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results

August 14, 2023

From Design Therapeutics, Inc.

Via GlobeNewswire

Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia

August 14, 2023

From Design Therapeutics, Inc.

Via GlobeNewswire

Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated ↗

July 28, 2023

Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of

Via Benzinga

Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗

June 27, 2023

Gainers

Via Benzinga

Design Therapeutics to Present at the 2023 Jefferies Healthcare Conference

May 31, 2023

From Design Therapeutics, Inc.

Via GlobeNewswire

Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial Results

May 09, 2023

From Design Therapeutics, Inc.

Via GlobeNewswire

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 26, 2023

Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023 ↗

May 04, 2023

Via Benzinga

Design Therapeutics to Present Preclinical Data on its GeneTAC™ Small Molecule, DT-168, for the Treatment of Fuchs Endothelial Corneal Dystrophy at ARVO 2023

April 24, 2023

From Design Therapeutics, Inc.

Via GlobeNewswire

Why Design Therapeutics (DSGN) Stock Is Going Nowhere But Down ↗

April 11, 2023

Design Therapeutics has multiple research programs and a strong drive to combat genetic disorders, but that's not enough to save DSGN stock.

Via InvestorPlace

Short Squeeze Stocks: BBBY, SI and 3 Other Stocks Ready to Squeeze ↗

March 27, 2023

Short squeeze stocks are all over Wall Street in the wake of the regional banking crisis. Which names should you keep an eye out for?

Via InvestorPlace

Short Interest Update - Monday, March 27 ↗

March 27, 2023

Although equities broadly are starting the new week higher, the most heavily shorted stocks are trading lower today.

Via Talk Markets

First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday ↗

March 17, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 17, 2023

Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.

Via Benzinga

Design Therapeutics Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results

March 14, 2023

From Design Therapeutics, Inc.

Via GlobeNewswire

Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗

March 13, 2023

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Design Therapeutics, Inc. (NASDAQ:DSGN) Investor Alert: Investigation Concerning Possible Wrongdoing ↗

March 08, 2023

San Diego, CA -- (SBWIRE) -- 03/08/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Design Therapeutics, Inc.

Via SBWire

Stocks That Hit 52-Week Lows On Wednesday ↗

February 15, 2023

On Wednesday, 35 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.